Skip to main content

Peer Review reports

From: Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

Original Submission
8 Feb 2022 Submitted Original manuscript
28 Apr 2022 Author responded Author comments - Julia Wendler
Resubmission - Version 2
28 Apr 2022 Submitted Manuscript version 2
19 May 2022 Author responded Author comments - Julia Wendler
Resubmission - Version 3
19 May 2022 Submitted Manuscript version 3
Publishing
31 May 2022 Editorially accepted
10 Sep 2022 Article published 10.1186/s12885-022-09723-w

You can find further information about peer review here.

Back to article page